ANSYS has patented a system and method for modeling vasculature flow in real-time. By combining reduced order and 0D models, physicians can personalize vascular system models for patients, predicting treatment effects accurately. The method involves receiving 3D data, determining a 0D model, generating boundary conditions, and creating a reduced order model for real-time flow simulation. GlobalData’s report on ANSYS gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on ANSYS, Capillary blood collection devices was a key innovation area identified from patents. ANSYS's grant share as of January 2024 was 53%. Grant share is based on the ratio of number of grants to total number of patents.
Modeling flow of vasculature using reduced order and 0d models
A recently granted patent (Publication Number: US11887737B2) discloses a computer-readable medium storing instructions that, when executed by a system's processors, enables the system to perform a method for analyzing vasculature. The method involves receiving 3D data of a vessel segment, creating a 0D model of the segment based on fluid simulations, generating boundary conditions, and developing a real-time reduced order model of the vessel segment to represent flow dynamics. The system can also adjust the model based on measured flow data, update parameters, and estimate hemodynamic characteristics of the vasculature.
Furthermore, the patent describes a system equipped with memory to receive 3D data and measured flow data, along with processors to implement the method outlined in the patent. This system can determine a 0D model of a vessel segment, generate simulated flow data based on a vascular system model, and adjust the model of the vasculature based on a comparison of simulated and measured flow data. The system can also update parameters, simulate flow in real-time, and utilize a medical scanner to generate measured flow data, showcasing a comprehensive approach to analyzing vasculature for medical applications.
To know more about GlobalData’s detailed insights on ANSYS, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
